![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/23 | |
A61K 31/225 | |||
A61P 3/00 | |||
A61P 3/02 | |||
A61P 25/08 |
(11) | Number of the document | 2931269 |
(13) | Kind of document | T |
(96) | European patent application number | 13862044.8 |
Date of filing the European patent application | 2013-12-13 | |
(97) | Date of publication of the European application | 2015-10-21 |
(45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/075146 |
Date | 2013-12-13 |
(87) | Number | WO 2014/093901 |
Date | 2014-06-19 |
(30) | Number | Date | Country code |
201261737013 P | 2012-12-13 | US | |
201361779942 P | 2013-03-13 | US |
(72) |
SCHIFFMANN, Raphael, US
MOCHEL, Fanny, FR
|
(73) |
Baylor Research Institute at Dallas,
2001 Bryan Street, Suite 2200, Dallas, TX 75201,
US
National Institute of Health and Medical Research, 101 rue de Tolbiac, 75654 Paris, FR |
(54) | TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORTER 1 DEFICIENCY |
TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORTER 1 DEFICIENCY |